Q3 2024 Earnings Call Transcript November 5, 2024 Masimo Corporation beats earnings expectations. Reported EPS is $0.98, expectations were $0.84. Operator: Ladies and gentlemen, good afternoon, and ...

MAMO sees a 30.7% increase in non-GAAP operating income in Q3 2024. Healthcare segment revenues increase 11.5%, driving overall growth amid strategic shifts.

NHL 25 received a new update this week that adds all 32 coaches into the game, and new patch notes with several improvements.

The consensus rating for Masimo is Buy, based on 2 analyst ratings. With an average one-year price target of $167.5, there's a potential 16.14% upside.

The Cigna Group CI is scheduled to release third-quarter 2024 results on Oct. 31, before the opening bell. The Zacks ...

A Delaware jury has ruled in favor of Apple in a patent infringement case against Masimo, awarding Cupertino a symbolic $250 ...

A Delaware jury has found health tech company Masimo guilty of infringing Apple’s Apple Watch patents on health technology, but limited it to only older smartwatch models that are no longer sold, and ...

The intense legal feud between Apple and medical technology company Masimo has reached a pivotal moment with Apple winning a nominal victory in the latest round of court battles. A federal jury ...

Apple wins a symbolic $250 in damages as a federal jury finds that Masimo's smartwatch designs and charger infringe on Apple Watch patents. Despite the minimal monetary award, Apple claims the ...

Apple said in a statement that it was "glad the jury's decision today will protect the innovations we advance on behalf of our customers." ...

A federal jury ruled Friday that Masimo smartwatches infringed Apple patents, but Apple isn’t getting a big payday. Bloomberg Law reports that the company was only seeking the statutory minimum ...